Cargando…
Developing and characterizing a two-layered safety switch for cell therapies
Gene edited and engineered cell-based therapies are a promising approach for treating a variety of disorders, including cancer. However, the ability of engineered cells to persist for prolonged periods along with possible toxicity raises concerns over the safety of these approaches. Although a numbe...
Autores principales: | Rossignoli, Filippo, Hoffman, Danielle, Atif, Emaan, Shah, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348026/ https://www.ncbi.nlm.nih.gov/pubmed/37439774 http://dx.doi.org/10.1080/15384047.2023.2232146 |
Ejemplares similares
-
Development of an inducible caspase-9 safety switch for pluripotent stem cell–based therapies
por: Wu, Chuanfeng, et al.
Publicado: (2014) -
Adoptive T-cell therapy: adverse events and safety switches
por: Tey, Siok-Keen
Publicado: (2014) -
Optimization of Thymidine Kinase-Based Safety Switch for Neural Cell Therapy
por: Locatelli, Manon, et al.
Publicado: (2022) -
Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches
por: Duong, MyLinh T., et al.
Publicado: (2018) -
Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety
por: Lian, Jiang-Shan, et al.
Publicado: (2019)